DK0574402T3 - Ekspression af PACE i værtsceller og fremgangsmåder til anvendelse deraf - Google Patents
Ekspression af PACE i værtsceller og fremgangsmåder til anvendelse derafInfo
- Publication number
- DK0574402T3 DK0574402T3 DK92901535.2T DK92901535T DK0574402T3 DK 0574402 T3 DK0574402 T3 DK 0574402T3 DK 92901535 T DK92901535 T DK 92901535T DK 0574402 T3 DK0574402 T3 DK 0574402T3
- Authority
- DK
- Denmark
- Prior art keywords
- pace
- expression
- methods
- host cells
- amino acid
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6424—Serine endopeptidases (3.4.21)
- C12N9/6454—Dibasic site splicing serine proteases, e.g. kexin (3.4.21.61); furin (3.4.21.75) and other proprotein convertases
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/745—Blood coagulation or fibrinolysis factors
- C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Hematology (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Enzymes And Modification Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US62109290A | 1990-11-26 | 1990-11-26 | |
US62144390A | 1990-11-29 | 1990-11-29 | |
US62085990A | 1990-11-29 | 1990-11-29 | |
US62145790A | 1990-11-30 | 1990-11-30 |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0574402T3 true DK0574402T3 (da) | 1998-05-18 |
Family
ID=27505162
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK92901535.2T DK0574402T3 (da) | 1990-11-26 | 1991-11-26 | Ekspression af PACE i værtsceller og fremgangsmåder til anvendelse deraf |
Country Status (10)
Country | Link |
---|---|
US (3) | US5460950A (da) |
EP (2) | EP0785273A1 (da) |
JP (2) | JP4236698B2 (da) |
AT (1) | ATE158816T1 (da) |
CA (1) | CA2096418C (da) |
DE (1) | DE69127829T2 (da) |
DK (1) | DK0574402T3 (da) |
ES (1) | ES2109336T3 (da) |
IE (1) | IE914102A1 (da) |
WO (1) | WO1992009698A1 (da) |
Families Citing this family (114)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5935815A (en) * | 1989-10-25 | 1999-08-10 | Katholieke Universiteit Leuven | Process for micro biological production of proteins |
EP0785273A1 (en) * | 1990-11-26 | 1997-07-23 | Genetics Institute, Inc. | Paired basic amino acid converting enzyme and DNA sequence encoding it |
US5965789A (en) * | 1991-01-11 | 1999-10-12 | American Red Cross | Engineering protein posttranslational modification by PACE/furin in transgenic non-human mammals |
US6348327B1 (en) * | 1991-12-06 | 2002-02-19 | Genentech, Inc. | Non-endocrine animal host cells capable of expressing variant proinsulin and processing the same to form active, mature insulin and methods of culturing such cells |
WO1993018159A2 (en) * | 1992-03-09 | 1993-09-16 | Chiron Corporation | Compositions and methods for pace 4 and 4.1 gene and polypeptides in cells |
US5846802A (en) * | 1992-04-15 | 1998-12-08 | Buxton; Frank | Fungal Protease |
CA2147623C (en) | 1992-10-23 | 2005-05-03 | Glenn R. Larsen | Novel p-selectin ligand protein |
US6277975B1 (en) * | 1992-10-23 | 2001-08-21 | Genetics Institute, Inc. | Fusions of P-selectin ligand protein and polynucleotides encoding same |
US5604201A (en) * | 1993-01-08 | 1997-02-18 | State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education On Behalf Of The Oregon Health Sciences University, A Non-Profit Organization | Methods and reagents for inhibiting furin endoprotease |
US5710044A (en) * | 1995-02-27 | 1998-01-20 | Abbott Laboratories | Plasmid for expressing phosphorylated recombinant proteins in a bacterial system |
US5807702A (en) * | 1995-02-27 | 1998-09-15 | Abbott Laboratories | Method for expressing phosphorylated recombinant human β-casein in a bacterial system |
JPH11500918A (ja) * | 1995-02-27 | 1999-01-26 | アボツト・ラボラトリーズ | 細菌系内で修飾組換えタンパク質を発現させるための方法 |
US5942254A (en) * | 1995-02-27 | 1999-08-24 | Abbott Laboratories | Phosphorylated recombinant human β-casein expressed in a bacterial system |
EP0812362A1 (en) * | 1995-02-27 | 1997-12-17 | Abbott Laboratories | A plasmid for expressing modified recombinant proteins in a bacterial system |
AT404838B (de) | 1995-11-24 | 1999-03-25 | Immuno Ag | Herstellung von proteinen aus pro-proteinen durch fusionsproteine abgeleitet von furin oder furinanalogen |
JPH09295945A (ja) * | 1996-04-30 | 1997-11-18 | Hoechst Yakuhin Kogyo Kk | 成熟型骨誘導因子の製造方法 |
US6518411B1 (en) * | 1996-11-22 | 2003-02-11 | University Of Iowa | RGS compositions and therapeutic and diagnostic uses therefor |
AT405517B (de) | 1997-02-27 | 1999-09-27 | Immuno Ag | Faktor x-deletionsmutanten und analoge davon |
AT405516B (de) * | 1997-02-27 | 1999-09-27 | Immuno Ag | Faktor x-analoge mit modifizierter proteasespaltstelle |
GB9704305D0 (en) * | 1997-03-01 | 1997-04-23 | Univ Manchester | Procollagen assembly |
US7081519B1 (en) | 1997-04-24 | 2006-07-25 | Zymogenetics, Inc. | Antibodies to serine protease polypeptides |
US6153420A (en) * | 1997-04-24 | 2000-11-28 | Zymogenetics, Inc. | Serine protease polypeptides and materials and methods for making them |
US6013503A (en) * | 1997-05-06 | 2000-01-11 | Zymogenetics, Inc. | Human prohormone convertase 4 |
US7247708B2 (en) * | 1997-10-23 | 2007-07-24 | Regents Of The University Of Minnesota | Modified vitamin K-dependent polypeptides |
US6747003B1 (en) | 1997-10-23 | 2004-06-08 | Regents Of The University Of Minnesota | Modified vitamin K-dependent polypeptides |
US6642011B2 (en) * | 1998-04-15 | 2003-11-04 | Genencor International, Inc. | Human protease and use of such protease for pharmaceutical applications and for reducing the allergenicity of non-human proteins |
CA2249648A1 (en) * | 1998-11-04 | 2000-05-04 | Nabil G. Seidah | Mammalian subtilisin/kexin isozyme ski-1: a proprotein convertase with a unique cleavage specificity |
WO2000028065A1 (en) * | 1998-11-06 | 2000-05-18 | Novo Nordisk A/S | Method for the production of fvii |
AT410216B (de) | 1999-08-10 | 2003-03-25 | Baxter Ag | Faktor x-analogon mit verbesserter aktivierbarkeit |
US6511832B1 (en) * | 1999-10-06 | 2003-01-28 | Texas A&M University System | In vitro synthesis of capped and polyadenylated mRNAs using baculovirus RNA polymerase |
CA2392076A1 (en) * | 1999-11-19 | 2001-05-25 | Solvay Pharmaceuticals B.V. | Human enzymes of the metalloprotease family |
ATE428445T1 (de) | 2000-02-11 | 2009-05-15 | Bayer Healthcare Llc | Gerinnungsfaktor vii oder viia konjugate |
US7812132B2 (en) * | 2000-04-28 | 2010-10-12 | Regents Of The University Of Minnesota | Modified vitamin K-dependent polypeptides |
US7220837B1 (en) | 2000-04-28 | 2007-05-22 | Regents Of The University Of Minnesota | Modified vitamin K-dependent polypeptides |
US6596526B1 (en) * | 2000-06-09 | 2003-07-22 | Baxter Aktiengesellschaft | Furin polypeptides with improved characteristics |
US20040047853A1 (en) * | 2000-06-09 | 2004-03-11 | Dahl Soren W | Purified proenzyme of dipeptidyl peptidase i (pro-dppi) |
US20030211094A1 (en) * | 2001-06-26 | 2003-11-13 | Nelsestuen Gary L. | High molecular weight derivatives of vitamin k-dependent polypeptides |
WO2002029045A2 (en) * | 2000-10-02 | 2002-04-11 | Novo Nordisk A/S | Method for the production of vitamin k-dependent proteins |
AU2002225681A1 (en) * | 2000-11-15 | 2002-05-27 | Globe Immune, Inc. | Yeast-dentritic cell vaccines and uses thereof |
PL367093A1 (en) * | 2001-05-18 | 2005-02-21 | Solvay Pharmaceuticals Gmbh | Use of compounds with combined nep/mp-inhibitory activity in the preparation of medicaments |
US20040143104A1 (en) * | 2001-08-08 | 2004-07-22 | Wadsworth Samuel C. | Methods of treating diabetes and other blood sugar disorders |
JP2005509409A (ja) * | 2001-08-08 | 2005-04-14 | ジェンザイム・コーポレーション | 糖尿病および他の血糖疾患の治療方法 |
CA2483478A1 (en) * | 2002-04-30 | 2003-11-13 | Maxygen Holdings Ltd. | Factor vii or viia polypeptide variants |
WO2003100053A1 (en) * | 2002-05-22 | 2003-12-04 | The Children's Hospital Of Philadelphia | Compositions and methods for the treatment of hemophilia a |
US7771996B2 (en) * | 2003-03-20 | 2010-08-10 | Bayer Healthcare Llc | FVII or FVIIa variants |
TWI353991B (en) | 2003-05-06 | 2011-12-11 | Syntonix Pharmaceuticals Inc | Immunoglobulin chimeric monomer-dimer hybrids |
DK1644504T3 (da) * | 2003-06-19 | 2010-05-25 | Bayer Healthcare Llc | Faktor VII- eller -VIIA-Gla-domænevarianter |
AU2004275828B2 (en) | 2003-09-23 | 2010-04-29 | University Of North Carolina At Chapel Hill | Methods and compositions for the correlation of single nucleotide polymorphisms in the vitamin K epoxide reductase gene and warfarin dosage |
US20050107318A1 (en) * | 2003-11-17 | 2005-05-19 | Samuel Wadsworth | Methods of treating diabetes and other blood sugar disorders |
US20050196864A1 (en) * | 2004-02-10 | 2005-09-08 | Goldman Steven A. | Induction and high-yield preparative purification of mesencephalic dopaminergic neuronal progenitor cells and dopaminergic neurons from human embryonic stem cells |
US20060003958A1 (en) * | 2004-05-11 | 2006-01-05 | Melville Mark W | Novel polynucleotides related to oligonucleotide arrays to monitor gene expression |
CA2571292C (en) * | 2004-06-30 | 2013-05-21 | Nektar Therapeutics Al, Corporation | Polymer-factor ix moiety conjugates |
US20070066551A1 (en) * | 2004-09-07 | 2007-03-22 | Keefe Anthony D | Aptamer medicinal chemistry |
US7566701B2 (en) * | 2004-09-07 | 2009-07-28 | Archemix Corp. | Aptamers to von Willebrand Factor and their use as thrombotic disease therapeutics |
CA2579374A1 (en) * | 2004-09-07 | 2006-03-30 | Archemix Corp. | Aptamers to von willebrand factor and their use as thrombotic disease therapeutics |
JP2008532544A (ja) | 2005-03-15 | 2008-08-21 | ユニヴァーシティ・オヴ・ノース・キャロライナ・アト・チャペル・ヒル | 活性ビタミンk依存性タンパク質を生産するための方法及び組成物 |
US20070053996A1 (en) | 2005-07-22 | 2007-03-08 | Boyden Edward S | Light-activated cation channel and uses thereof |
US8926959B2 (en) | 2005-07-22 | 2015-01-06 | The Board Of Trustees Of The Leland Stanford Junior University | System for optical stimulation of target cells |
US10052497B2 (en) | 2005-07-22 | 2018-08-21 | The Board Of Trustees Of The Leland Stanford Junior University | System for optical stimulation of target cells |
US9274099B2 (en) | 2005-07-22 | 2016-03-01 | The Board Of Trustees Of The Leland Stanford Junior University | Screening test drugs to identify their effects on cell membrane voltage-gated ion channel |
US9238150B2 (en) | 2005-07-22 | 2016-01-19 | The Board Of Trustees Of The Leland Stanford Junior University | Optical tissue interface method and apparatus for stimulating cells |
PL1969127T5 (pl) * | 2005-12-21 | 2018-02-28 | Cnj Holdings, Inc | Metoda wytwarzania biologicznie czynnych białek zależnych od witaminy K metodami rekombinacji |
EP2004683B1 (en) * | 2006-03-24 | 2016-05-11 | Biogen Hemophilia Inc. | Pc5 as a factor ix propeptide processing enzyme |
DE602006009631D1 (de) | 2006-05-10 | 2009-11-19 | Biocompatibles Uk Ltd | GLP-1 Peptide enthaltende kugelförmige Mikrokapseln, deren Produktion und deren Verwendung |
US8398692B2 (en) | 2007-01-10 | 2013-03-19 | The Board Of Trustees Of The Leland Stanford Junior University | System for optical stimulation of target cells |
US8401609B2 (en) | 2007-02-14 | 2013-03-19 | The Board Of Trustees Of The Leland Stanford Junior University | System, method and applications involving identification of biological circuits such as neurological characteristics |
WO2008106694A2 (en) | 2007-03-01 | 2008-09-04 | The Board Of Trustees Of The Leland Stanford Junior University | Systems, methods and compositions for optical stimulation of target cells |
EP2517714A1 (en) | 2007-04-26 | 2012-10-31 | Inspiration Biopharmaceuticals, Inc. | Recombinant vitamin K dependent proteins with high sialic acid content and methods of preparing same |
PT2157177E (pt) | 2007-05-22 | 2013-04-18 | Baxter Int | Processo de purificação preparativo para a furina humana |
US20090203766A1 (en) * | 2007-06-01 | 2009-08-13 | Archemix Corp. | vWF aptamer formulations and methods for use |
US10035027B2 (en) | 2007-10-31 | 2018-07-31 | The Board Of Trustees Of The Leland Stanford Junior University | Device and method for ultrasonic neuromodulation via stereotactic frame based technique |
US10434327B2 (en) | 2007-10-31 | 2019-10-08 | The Board Of Trustees Of The Leland Stanford Junior University | Implantable optical stimulators |
SI2235197T1 (sl) | 2007-12-27 | 2017-10-30 | Baxalta GmbH | Procesi celične kulture |
BRPI0821467B8 (pt) | 2007-12-31 | 2021-05-25 | Baxalta GmbH | composição de furina recombinante, método para produzir a composição de furina recombinante, e, método para produzir uma proteína madura utilizando a composição de furina recombinante |
RU2010147661A (ru) | 2008-04-23 | 2012-05-27 | Дзе Борд Оф Трастиз Оф Дзе Лелэнд Стэнфорд Джуниор Юниверсити (Us) | Системы, способы и композиции для оптической стимуляции клеток-мишеней |
EP2610350B1 (en) | 2008-05-29 | 2014-12-17 | The Board Of Trustees Of The Leland Stanford Junior University | Cell line, system and method for optical control of secondary messengers |
AU2009260029B2 (en) | 2008-06-17 | 2016-03-17 | The Board Of Trustees Of The Leland Stanford Junior University | Methods, systems and devices for optical stimulation of target cells using an optical transmission element |
US10711242B2 (en) | 2008-06-17 | 2020-07-14 | The Board Of Trustees Of The Leland Stanford Junior University | Apparatus and methods for controlling cellular development |
WO2010006049A1 (en) | 2008-07-08 | 2010-01-14 | The Board Of Trustees Of The Leland Stanford Junior University | Materials and approaches for optical stimulation of the peripheral nervous system |
EP2163243A1 (en) | 2008-09-12 | 2010-03-17 | Biocompatibles UK Limited | Treatment of acute myocardial infarction (AMI) using encapsulated cells encoding and secreting GLP-1 peptides or analogs thereof |
NZ602416A (en) | 2008-11-14 | 2014-08-29 | Univ Leland Stanford Junior | Optically-based stimulation of target cells and modifications thereto |
EP2251028A1 (en) | 2009-05-12 | 2010-11-17 | Biocompatibles Uk Ltd. | Treatment of eye diseases using encapsulated cells encoding and secreting an anti-angiogenic factor and/or a neuroprotective factor |
AU2011227131B2 (en) | 2010-03-17 | 2014-11-13 | The Board Of Trustees Of The Leland Stanford Junior University | Light-sensitive ion-passing molecules |
PL2591006T3 (pl) | 2010-07-09 | 2019-10-31 | Bioverativ Therapeutics Inc | Przetwarzalne cząsteczki jednołańcuchowe i polipeptydy wytworzone przy ich zastosowaniu |
EP2591101B1 (en) * | 2010-07-09 | 2018-11-07 | Bioverativ Therapeutics Inc. | Systems for factor viii processing and methods thereof |
WO2012034704A1 (en) | 2010-09-15 | 2012-03-22 | Biocompatibles Uk Ltd. | Treatment of vascular diseases using encapsulated cells encoding and secreting glp-1, or a fragment or variant thereof |
EP2635346B1 (en) | 2010-11-05 | 2017-03-29 | The Board of Trustees of the Leland Stanford Junior University | Optogenetic control of reward-related behaviors |
EP2635108B1 (en) | 2010-11-05 | 2019-01-23 | The Board of Trustees of the Leland Stanford Junior University | Light-activated chimeric opsins and methods of using the same |
CN105941328B (zh) | 2010-11-05 | 2019-04-09 | 斯坦福大学托管董事会 | 一种鉴定抑制前额叶皮质中的兴奋性或抑制性神经元的去极化的化合物的系统 |
JP6328424B6 (ja) | 2010-11-05 | 2018-07-11 | ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティー | 記憶機能の制御および特性化 |
CA2816968C (en) | 2010-11-05 | 2019-11-26 | The Board Of Trustees Of The Leland Stanford Junior University | Optically-controlled cns dysfunction |
CN110215614A (zh) | 2010-11-05 | 2019-09-10 | 斯坦福大学托管董事会 | 用于光遗传学方法的光的上转换 |
US8696722B2 (en) | 2010-11-22 | 2014-04-15 | The Board Of Trustees Of The Leland Stanford Junior University | Optogenetic magnetic resonance imaging |
EP2655607A4 (en) | 2010-12-21 | 2014-05-14 | Univ North Carolina | METHOD AND COMPOSITIONS FOR PRODUCING ACTIVE VITAMIN K-DEPENDENT PROTEINS |
WO2012122611A1 (en) * | 2011-03-11 | 2012-09-20 | Universidade De São Paulo - Usp | Method for the production of recombinant human factor viii |
SG195261A1 (en) | 2011-06-02 | 2013-12-30 | Baxter Int | Formulations of recombinant furin |
CN104093833B (zh) | 2011-12-16 | 2017-11-07 | 斯坦福大学托管董事会 | 视蛋白多肽及其使用方法 |
US20130230901A1 (en) * | 2012-02-14 | 2013-09-05 | Portola Pharmaceuticals, Inc. | Process for making recombinant antidote to factor xa inhibitor |
EP2817068B1 (en) | 2012-02-21 | 2017-04-12 | The Board of Trustees of the Leland Stanford Junior University | Compositions for treating neurogenic disorders of the pelvic floor |
JP2015525222A (ja) | 2012-06-08 | 2015-09-03 | バイオジェン・エムエイ・インコーポレイテッドBiogen MA Inc. | キメラ性凝固因子 |
CA2875246A1 (en) | 2012-06-08 | 2013-12-12 | Biogen Idec Ma Inc. | Procoagulant compounds |
TWI828269B (zh) | 2013-03-15 | 2024-01-01 | 美商百歐維拉提夫治療公司 | 因子ix多肽調配物 |
EP2968997B1 (en) | 2013-03-15 | 2019-06-26 | The Board of Trustees of the Leland Stanford Junior University | Optogenetic control of behavioral state |
US9636380B2 (en) | 2013-03-15 | 2017-05-02 | The Board Of Trustees Of The Leland Stanford Junior University | Optogenetic control of inputs to the ventral tegmental area |
WO2014179331A2 (en) | 2013-04-29 | 2014-11-06 | The Board Of Trustees Of The Leland Stanford Junior University | Devices, systems and methods for optogenetic modulation of action potentials in target cells |
AU2014306679A1 (en) | 2013-08-14 | 2016-03-10 | Circuit Therapeutics, Inc. | Compositions and methods for controlling pain |
JP6640198B2 (ja) | 2014-05-26 | 2020-02-05 | アカデ−ミッシュ ズィーケンハウス ライデンAcademisch Ziekenhuis Leiden | 出血治療のための止血促進タンパク質 |
TWI666319B (zh) * | 2014-08-12 | 2019-07-21 | 美商巴克斯歐塔公司 | 在分泌furin之哺乳動物表現系統中生產經完全加工且具功能性之因子X |
JP7095990B2 (ja) | 2014-09-18 | 2022-07-05 | シーダーズ-サイナイ メディカル センター | 線維症を治療するための組成物及び方法 |
MA40835A (fr) | 2014-10-23 | 2017-08-29 | Biogen Ma Inc | Anticorps anti-gpiib/iiia et leurs utilisations |
MA40861A (fr) | 2014-10-31 | 2017-09-05 | Biogen Ma Inc | Anticorps anti-glycoprotéines iib/iiia |
CN107708718B (zh) | 2015-04-22 | 2022-01-11 | 西达-赛奈医疗中心 | 用于治疗2型糖尿病的肠内递送的苦味寡肽 |
WO2016209654A1 (en) | 2015-06-22 | 2016-12-29 | The Board Of Trustees Of The Leland Stanford Junior University | Methods and devices for imaging and/or optogenetic control of light-responsive neurons |
US11294165B2 (en) | 2017-03-30 | 2022-04-05 | The Board Of Trustees Of The Leland Stanford Junior University | Modular, electro-optical device for increasing the imaging field of view using time-sequential capture |
Family Cites Families (61)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2855719A1 (de) | 1978-12-22 | 1980-07-10 | Siemens Ag | Zahnaerztliche handstueckanordnung |
US4336336A (en) | 1979-01-12 | 1982-06-22 | President And Fellows Of Harvard College | Fused gene and method of making and using same |
US4399216A (en) | 1980-02-25 | 1983-08-16 | The Trustees Of Columbia University | Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials |
AU545912B2 (en) | 1980-03-10 | 1985-08-08 | Cetus Corporation | Cloned heterologous jive products in bacillies |
ZA811368B (en) | 1980-03-24 | 1982-04-28 | Genentech Inc | Bacterial polypedtide expression employing tryptophan promoter-operator |
US4419446A (en) | 1980-12-31 | 1983-12-06 | The United States Of America As Represented By The Department Of Health And Human Services | Recombinant DNA process utilizing a papilloma virus DNA as a vector |
NZ199722A (en) | 1981-02-25 | 1985-12-13 | Genentech Inc | Dna transfer vector for expression of exogenous polypeptide in yeast;transformed yeast strain |
DK188582A (da) | 1981-04-29 | 1982-10-30 | Biogen Nv | Bacillus-kloningsvektorer rekombinations-dna-molekyler bacillus-vaerter transformeret dermed samt fremgangsmaader til ekspressionaf fremmede dna-sekvenser og fremstilling af polypeptideer som er kodede dermed |
US4551433A (en) | 1981-05-18 | 1985-11-05 | Genentech, Inc. | Microbial hybrid promoters |
US4652639A (en) * | 1982-05-06 | 1987-03-24 | Amgen | Manufacture and expression of structural genes |
US4876197A (en) | 1983-02-22 | 1989-10-24 | Chiron Corporation | Eukaryotic regulatable transcription |
CA1341302C (en) | 1983-02-22 | 2001-10-09 | Rae Lyn Burke | Yeast expression systems with vectors having gapdh or pyk promoters and synthesis of foreign protein |
JPS59166086A (ja) | 1983-03-09 | 1984-09-19 | Teruhiko Beppu | 新規な発現型プラスミドとそれらを用いて仔牛プロキモシン遺伝子を大腸菌内で発現させる方法 |
US4546083A (en) | 1983-04-22 | 1985-10-08 | Stolle Research & Development Corporation | Method and device for cell culture growth |
US4588684A (en) | 1983-04-26 | 1986-05-13 | Chiron Corporation | a-Factor and its processing signals |
JPS59205983A (ja) | 1983-04-28 | 1984-11-21 | ジエネツクス・コ−ポレイシヨン | 異種遺伝子を原核微生物で発現させる方法 |
US4663280A (en) | 1983-05-19 | 1987-05-05 | Public Health Research Institute Of The City Of New York | Expression and secretion vectors and method of constructing vectors |
US4745051A (en) * | 1983-05-27 | 1988-05-17 | The Texas A&M University System | Method for producing a recombinant baculovirus expression vector |
US4689406A (en) | 1983-08-10 | 1987-08-25 | Amgen | Enhancement of microbial expression of polypeptides |
US4870008A (en) | 1983-08-12 | 1989-09-26 | Chiron Corporation | Secretory expression in eukaryotes |
EP0136907A3 (en) | 1983-10-03 | 1986-12-30 | Genentech, Inc. | A xenogeneic expression control system, a method of using it, expression vectors containing it, cells transformed thereby and heterologous proteins produced therefrom |
US4703008A (en) * | 1983-12-13 | 1987-10-27 | Kiren-Amgen, Inc. | DNA sequences encoding erythropoietin |
US4740461A (en) | 1983-12-27 | 1988-04-26 | Genetics Institute, Inc. | Vectors and methods for transformation of eucaryotic cells |
EP0164556B1 (en) | 1984-05-11 | 1994-03-02 | Chiron Corporation | Enhanced yeast transcription employing hybrid promoter region constructs |
US4880734A (en) | 1984-05-11 | 1989-11-14 | Chiron Corporation | Eukaryotic regulatable transcription |
US5077204A (en) * | 1984-06-21 | 1991-12-31 | Chiron Corporation | Yeast endopeptidase for basic amino-acid site cleavage, preparation and use |
US4738921A (en) | 1984-09-27 | 1988-04-19 | Eli Lilly And Company | Derivative of the tryptophan operon for expression of fused gene products |
US4745056A (en) | 1984-10-23 | 1988-05-17 | Biotechnica International, Inc. | Streptomyces secretion vector |
US4837148A (en) | 1984-10-30 | 1989-06-06 | Phillips Petroleum Company | Autonomous replication sequences for yeast strains of the genus pichia |
US4683202A (en) | 1985-03-28 | 1987-07-28 | Cetus Corporation | Process for amplifying nucleic acid sequences |
US4683195A (en) | 1986-01-30 | 1987-07-28 | Cetus Corporation | Process for amplifying, detecting, and/or-cloning nucleic acid sequences |
EP0196056B1 (en) | 1985-03-28 | 1991-05-22 | Chiron Corporation | Improved expression using fused genes providing for protein product |
GR860984B (en) * | 1985-04-17 | 1986-08-18 | Zymogenetics Inc | Expression of factor vii and ix activities in mammalian cells |
JP2584443B2 (ja) * | 1985-04-22 | 1997-02-26 | ジエネテイツクス・インスチチユ−ト・インコ−ポレ−テツド | 活性化▲i▼▲x▼因子の高収率産生 |
US4865974A (en) | 1985-09-20 | 1989-09-12 | Cetus Corporation | Bacterial methionine N-terminal peptidase |
ATE110111T1 (de) | 1986-05-02 | 1994-09-15 | Gist Brocades Nv | Sekretionssignal-selektionsvektoren für extrazelluläre proteinsynthese in bazillen. |
EP0246709A1 (en) * | 1986-05-20 | 1987-11-25 | Stichting Katholieke Universiteit | Recombinant DNA and cDNA, mRNA, protein, antibodies, and a method of detecting tumor cells |
US4959455A (en) | 1986-07-14 | 1990-09-25 | Genetics Institute, Inc. | Primate hematopoietic growth factors IL-3 and pharmaceutical compositions |
ATE247708T1 (de) | 1986-10-02 | 2003-09-15 | Massachusetts Inst Technology | Verfahren zur regulierung der metabolischen stabilität von proteinen |
JPS63123383A (ja) | 1986-11-11 | 1988-05-27 | Mitsubishi Kasei Corp | ハイブリツドプロモ−タ−、発現調節dna配列および発現ベクタ− |
US4912040A (en) | 1986-11-14 | 1990-03-27 | Genetics Institute, Inc. | Eucaryotic expression system |
US4870023A (en) * | 1987-03-16 | 1989-09-26 | American Biogenetic Sciences, Inc. | Recombinant baculovirus occlusion bodies in vaccines and biological insecticides |
DK175243B1 (da) | 1987-03-23 | 2004-07-19 | Zymogenetics Inc | Ekspressionsvektor, der er i stand til at styre ekspression af heterologe gener eller cDNA i gær, gærværtscelle samt fremgangsmåde til öget produktion af proteiner i gærværtsceller |
GB8712540D0 (en) * | 1987-05-28 | 1987-07-01 | Ucb Sa | Expression of human proapolipoprotein a-i |
US4929553A (en) * | 1987-05-29 | 1990-05-29 | Canadian Patents & Development Ltd. | Protease for specific processing of secreted proteins |
US5041378A (en) * | 1987-08-11 | 1991-08-20 | Cetus Corporation | Procaryotic xylose isomerase muteins |
DK463887D0 (da) | 1987-09-07 | 1987-09-07 | Novo Industri As | Gaerleader |
US4929555A (en) | 1987-10-19 | 1990-05-29 | Phillips Petroleum Company | Pichia transformation |
US4992373A (en) * | 1987-12-04 | 1991-02-12 | Eli Lilly And Company | Vectors and compounds for direct expression of activated human protein C |
CA1340740C (en) * | 1987-12-08 | 1999-09-14 | Eileen R. Mulvihill | Co-expression in eukaryotic cells |
CA1340772C (en) | 1987-12-30 | 1999-09-28 | Patricia Tekamp-Olson | Expression and secretion of heterologous protiens in yeast employing truncated alpha-factor leader sequences |
US4973551A (en) | 1988-01-15 | 1990-11-27 | Merck & Co., Inc. | Vector for the expression of fusion proteins and protein immunogens |
JP2643968B2 (ja) * | 1988-02-03 | 1997-08-25 | サントリー株式会社 | Kex2エンドプロテアーゼ及びその製造方法 |
IL89790A (en) * | 1988-04-01 | 2002-05-23 | Johns Hopking University | Sequences of nucleic acids encoding and cells producing CR1 protein and methods for its production and purification |
US5004803A (en) * | 1988-11-14 | 1991-04-02 | Genetics Institute, Inc. | Production of procoagulant proteins |
JP2693800B2 (ja) | 1988-12-28 | 1997-12-24 | 甲府日本電気株式会社 | 浮動小数点データ総和演算回路 |
NL9000917A (nl) * | 1989-10-25 | 1991-05-16 | Holland Biotechnology | Farmaceutisch preparaat met endoproteolytische activiteit; werkwijze voor endoproteolytische processing van (precursor) eiwitten en voor de (micro) biologische bereiding van eiwitten. |
CN1024746C (zh) * | 1989-12-20 | 1994-06-01 | 李清祈 | 具热能调节作用构件的煮器 |
EP0785273A1 (en) * | 1990-11-26 | 1997-07-23 | Genetics Institute, Inc. | Paired basic amino acid converting enzyme and DNA sequence encoding it |
US5780285A (en) * | 1995-03-03 | 1998-07-14 | Genentech, Inc. | Subtilisin variants capable of cleaving substrates containing dibasic residues |
CA2438874A1 (en) | 2001-03-14 | 2002-09-19 | Eli Lilly And Company | Fluorinated trienes and their use as rxr modulators |
-
1991
- 1991-11-26 EP EP96119683A patent/EP0785273A1/en not_active Withdrawn
- 1991-11-26 JP JP50154992A patent/JP4236698B2/ja not_active Expired - Lifetime
- 1991-11-26 AT AT92901535T patent/ATE158816T1/de not_active IP Right Cessation
- 1991-11-26 ES ES92901535T patent/ES2109336T3/es not_active Expired - Lifetime
- 1991-11-26 DE DE69127829T patent/DE69127829T2/de not_active Expired - Lifetime
- 1991-11-26 WO PCT/US1991/008725 patent/WO1992009698A1/en active IP Right Grant
- 1991-11-26 EP EP92901535A patent/EP0574402B2/en not_active Expired - Lifetime
- 1991-11-26 IE IE410291A patent/IE914102A1/en not_active IP Right Cessation
- 1991-11-26 DK DK92901535.2T patent/DK0574402T3/da active
- 1991-11-26 CA CA002096418A patent/CA2096418C/en not_active Expired - Lifetime
-
1992
- 1992-05-20 US US07/885,972 patent/US5460950A/en not_active Expired - Lifetime
-
1995
- 1995-06-07 US US08/480,382 patent/US5986079A/en not_active Expired - Lifetime
-
1996
- 1996-11-08 US US08/745,880 patent/US5965425A/en not_active Expired - Fee Related
-
2008
- 2008-03-14 JP JP2008066877A patent/JP2008194050A/ja not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
IE914102A1 (en) | 1992-06-03 |
EP0574402B1 (en) | 1997-10-01 |
CA2096418A1 (en) | 1992-05-27 |
EP0574402A4 (en) | 1994-08-24 |
ATE158816T1 (de) | 1997-10-15 |
WO1992009698A1 (en) | 1992-06-11 |
JPH06504435A (ja) | 1994-05-26 |
US5460950A (en) | 1995-10-24 |
CA2096418C (en) | 2001-11-20 |
EP0574402B2 (en) | 2012-08-01 |
JP4236698B2 (ja) | 2009-03-11 |
ES2109336T3 (es) | 1998-01-16 |
EP0574402A1 (en) | 1993-12-22 |
EP0785273A1 (en) | 1997-07-23 |
JP2008194050A (ja) | 2008-08-28 |
US5965425A (en) | 1999-10-12 |
DE69127829T2 (de) | 1998-03-19 |
US5986079A (en) | 1999-11-16 |
DE69127829D1 (de) | 1997-11-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0574402T3 (da) | Ekspression af PACE i værtsceller og fremgangsmåder til anvendelse deraf | |
DK219087A (da) | Vektorsystem til brug ved transformation af trichoderma, transformerede trichodermastammer og fremgangsmaade til fremstilling af proteiner heri | |
DK374087D0 (da) | Fremgangsmaade til fremstilling af proteiner med faktor viii-aktivitet ved hjaelp af mikrobielle voertsceller og ekspressionsvektorer, vaertsceller og antistoffer til anvendelse ved denne | |
IL68366A (en) | Process for expressing a gene encoding a protein comprising the enzymatic portion of human urokinase in a microorganism or cell culture | |
NO882946D0 (no) | Konstruksjon av syntetisk dna og anvendelse derav i syntese av store polypeptider. | |
DK371087D0 (da) | Mamalialt interleukin-4 | |
ATE79403T1 (de) | Herstellung von thrombin-inhibitoren. | |
DE3853886D1 (de) | Menschliche, erythroid-spezifische transkriptionsenhancer. | |
DE3882078D1 (de) | Amperometrische methode zur titration von nadh (1,4-dihydronicotinamid-adenine-dinucleotide) in loesung. | |
GR3019059T3 (en) | Human MK gene and protein sequence | |
FI882238A (fi) | Foerbaettringar i samband med organiska foereningar | |
DE209855T1 (de) | Aminosaeure-derivate, nuetzlich zur deaktivation von enzymen. | |
DE3780855D1 (de) | Zellkultur-methode. | |
DK489786D0 (da) | Kraftdreven griber, navnlig til manipulering af formparter og hermedsamvirkende dele i et automatiseret staeberianlaeg | |
FI934079A (fi) | Menetelmä fuusioproteiinin valmistamiseksi |